Actively Recruiting
Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Led by Epiliquid Holding, Inc · Updated on 2025-08-29
600
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
CASCADE (Colorectal Analysis for Signature Cancer Assessment Using delta-HLD Technology) is a proof-of-concept case-control study designed to evaluate the performance of delta-HLD, Epiliquid's proprietary liquid biopsy technology, for the detection of colorectal cancer. Epiliquid also integrates a proprietary bioinformatic system capable of identifying, ranking, and selecting tumor-specific methylation biomarkers for different cancer types. In this study, colorectal cancer-specific biomarkers will be evaluated in blood and tissue samples using delta-HLD technology, which enables sensitive and multiplexed detection through PCR. Study results will support the validation of Epiliquid's integrated platform as a minimally invasive and accessible diagnostic solution for colorectal cancer.
CONDITIONS
Official Title
Colorectal Analysis for Signature Cancer Assessment Using Delta-HLD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Candidate for colonoscopy or colorectal surgery
- Willing and able to provide informed consent
- Able to provide blood and/or tissue sample before treatment or resection
You will not qualify if you...
- Prior history of colorectal cancer
- Inflammatory bowel disease
- Known hereditary cancer syndromes (e.g., Lynch, FAP)
- Other active malignancies
- Recent chemotherapy or immunosuppressive treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Epiliquid
Mendoza, Argentina, 5500
Actively Recruiting
Research Team
D
Dr. Victoria Bocanegra, MD, PhD.
CONTACT
D
Dr. Emanuel Campoy, PhD.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here